Publication: The Repurposing Drugs in Oncology (ReDO) Project
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Cancer Intelligence
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Pantziarka, Pan, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme, Vikas P. Sukhatme, and P. Vikas. 2014. “The Repurposing Drugs in Oncology (ReDO) Project.” ecancermedicalscience 8 (1): 442. doi:10.3332/ecancer.2014.442. http://dx.doi.org/10.3332/ecancer.2014.442.
Research Data
Abstract
The Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and future patient needs. In addition to discussing the advantages of repurposing, the paper also outlines some of the characteristics used in the selection of drug candidates by this project. Challenges in moving candidate drugs into clinical trial and subsequent practice are also discussed.
Description
Other Available Sources
Keywords
drug repurposing, drug development, metronomics, health policy, health economics, ReDO Project
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service